
The stock isn’t just being priced — it’s being negotiated
Ashland is suddenly in that awkward moment where the market starts asking, “Are you worth more dead than alive?” Activists Cruiser Capital and Ancora are pushing for a sale of the company, arguing the stock has room to run if valuation catches up to listed peers and recent M&A comps.
Why the bulls are circling
The math here is doing a lot of heavy lifting. Ancora’s bull-case setup leans on a 13.8x EV/EBITDA target, which is basically Wall Street’s way of saying, “If you look enough like your peers, maybe you deserve a nicer outfit and a higher multiple.”
What could actually move the needle?
- A sale process if the board gets serious about activist pressure
- New product launches that juice revenue instead of just telling a nicer story on earnings calls
- Plant consolidation to cut costs and make margins less moody
- More buybacks if cash flow keeps improving, because nothing says “we like the stock too” like the company buying its own shares
Big picture
This is the kind of setup where the stock can start trading less like a steady industrial and more like a game of corporate chess. If the activists get traction, Ashland could turn into a classic value-unlock story — which is catnip for investors, and mildly stressful for management.
